Primary |
Uveitis |
40.0% |
Choroiditis |
6.7% |
Cystoid Macular Oedema |
5.0% |
Cytomegalovirus Chorioretinitis |
5.0% |
Iridocyclitis |
5.0% |
Psoriasis |
5.0% |
Behcet's Syndrome |
3.3% |
Diabetes Mellitus |
3.3% |
Eczema |
3.3% |
Intraocular Pressure Increased |
3.3% |
Intraocular Pressure Test |
3.3% |
Rash |
3.3% |
Anxiety |
1.7% |
Blood Cholesterol Increased |
1.7% |
Chorioretinitis |
1.7% |
Dermatitis Atopic |
1.7% |
Diabetic Retinal Oedema |
1.7% |
Drug Use For Unknown Indication |
1.7% |
Hypercholesterolaemia |
1.7% |
Hypertension |
1.7% |
|
Vitreous Floaters |
12.5% |
Drug Effect Decreased |
9.4% |
Corneal Decompensation |
6.3% |
Corneal Perforation |
6.3% |
Drug Ineffective |
6.3% |
Glaucoma |
6.3% |
Macular Oedema |
6.3% |
Urticaria |
6.3% |
Vitreous Haemorrhage |
6.3% |
Cataract |
3.1% |
Condition Aggravated |
3.1% |
Conjunctival Oedema |
3.1% |
Corneal Disorder |
3.1% |
Cytomegalovirus Infection |
3.1% |
Dermatitis Exfoliative |
3.1% |
Device Breakage |
3.1% |
Eczema |
3.1% |
Eye Colour Change |
3.1% |
Feeling Abnormal |
3.1% |
Herpes Ophthalmic |
3.1% |
|
Secondary |
Dermatitis Atopic |
16.7% |
Otitis Externa |
16.7% |
Uveitis |
13.3% |
Ill-defined Disorder |
8.3% |
Product Used For Unknown Indication |
8.3% |
Antiinflammatory Therapy |
6.7% |
Cytomegalovirus Chorioretinitis |
5.0% |
Melasma |
5.0% |
Cystoid Macular Oedema |
3.3% |
Diabetes Mellitus |
3.3% |
Bipolar Disorder |
1.7% |
Choroiditis |
1.7% |
Hypercholesterolaemia |
1.7% |
Hyperkeratosis |
1.7% |
Hypothyroidism |
1.7% |
Rash Papular |
1.7% |
Schizophrenia |
1.7% |
Vogt-koyanagi-harada Syndrome |
1.7% |
|
Tendon Rupture |
12.5% |
Drug Ineffective |
8.3% |
Herpes Simplex |
8.3% |
Ocular Neoplasm |
8.3% |
Condition Aggravated |
4.2% |
Device Breakage |
4.2% |
Drug Effect Decreased |
4.2% |
Joint Injury |
4.2% |
Meningitis |
4.2% |
Metastases To Eye |
4.2% |
Neuroleptic Malignant Syndrome |
4.2% |
Ochronosis |
4.2% |
Product Label Issue |
4.2% |
Product Quality Issue |
4.2% |
Retinal Tear |
4.2% |
Rotator Cuff Syndrome |
4.2% |
Scleritis |
4.2% |
Vitreous Fibrin |
4.2% |
Vitritis |
4.2% |
|
Concomitant |
Product Used For Unknown Indication |
26.2% |
Psoriasis |
14.4% |
Drug Use For Unknown Indication |
10.8% |
Pain |
8.3% |
Hormone Replacement Therapy |
3.6% |
Hypertension |
3.6% |
Multiple Myeloma |
3.3% |
Rheumatoid Arthritis |
3.3% |
Breast Cancer |
2.8% |
Contraception |
2.8% |
Gastrooesophageal Reflux Disease |
2.8% |
Chronic Hepatitis C |
2.2% |
Crohn's Disease |
2.2% |
Diabetes Mellitus |
2.2% |
Acne |
1.9% |
Hypersensitivity |
1.9% |
Infection |
1.9% |
Inflammatory Bowel Disease |
1.9% |
Prostate Cancer |
1.9% |
Psoriatic Arthropathy |
1.9% |
|
Wheezing |
12.9% |
Sepsis |
8.1% |
Pneumothorax |
6.5% |
Vaginal Discharge |
6.5% |
Wound Infection |
6.5% |
Blood Glucose Increased |
4.8% |
Death |
4.8% |
Hypokalaemia |
4.8% |
Liver Disorder |
4.8% |
Pruritus |
4.8% |
Psoriasis |
4.8% |
Tardive Dyskinesia |
4.8% |
Choking Sensation |
3.2% |
Dysuria |
3.2% |
Neutropenia |
3.2% |
Night Sweats |
3.2% |
Oedema Peripheral |
3.2% |
Pain |
3.2% |
Urinary Tract Infection |
3.2% |
Vomiting |
3.2% |
|